{
    "code": "10000914",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000914",
    "time": "2020-05-29 03:12:50",
    "許可證字號": "衛署菌疫輸字第000914號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/03\/03",
    "發證日期": "100\/03\/03",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000091407",
    "中文品名": "胰妥善注射液",
    "英文品名": "Victoza",
    "適應症": "血糖控制：\r\nVictoza®可單獨使用或與口服降血糖藥物及\/或基礎胰島素併用，適用於藉由飲食與運動仍未達理想血糖控制的第2型糖尿病病人，作為血糖控制之輔助治療。\r\n預防心血管事件：\r\nVictoza®用於已有心血管疾病的第2型糖尿病病人時，可降低發生主要心血管事件 (MACE：包括心血管疾病死亡、非致命性心肌梗塞、非致命性中風)之風險。",
    "劑型": "270注射劑",
    "包裝": "3mL注射筆裝 1~10支裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LIRAGLUTIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1426801100  台灣諾和諾德藥品股份有限公司",
    "申請商地址": "台北市大安區敦化南路2段207號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDK0020000  NOVO NORDISK A\/S",
            "製造廠廠址": "NOVO ALLE, DK-2880 BAGSVAERD, DENMARK",
            "製造廠公司地址": "NOVO ALLE, DK-2880 BAGSVAERD, DENMARK",
            "製造廠國別": "DENMARK",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDK0042000  NOVO NORDISK A\/S",
            "製造廠廠址": "HALLAS ALLE, DK-4400 KALUNDBORG, DENMARK",
            "製造廠公司地址": "",
            "製造廠國別": "DENMARK",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "FDK0053000  Novo Nordisk A\/S",
            "製造廠廠址": "Brennum Park DK-3400 Hilleroed, Denmark",
            "製造廠公司地址": "",
            "製造廠國別": "DENMARK",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200088700",
            "成分名稱": "LIRAGLUTIDE",
            "含量描述": "",
            "含量": "6.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Victoza筆-外觀-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000914&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Victoza STF2017 Leaflet (8-9695-10-001-6)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000914&Seq=008&Type=9"
        },
        {
            "title": "1. 2018-08-27_Victoza-適應症及仿單變更_核定之中文仿單_Final-v1_clean_20180829-107-08-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000914&Seq=007&Type=9"
        },
        {
            "title": "Victoza Carton (8-9695-10-301-4)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000914&Seq=018&Type=8"
        },
        {
            "title": "Victoza STF2013 Label (8-9695-10-201-2)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000914&Seq=017&Type=8"
        },
        {
            "title": "A01_2_Victoza_外盒標籤_20180330-107-03-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000914&Seq=016&Type=8"
        }
    ]
}